disease 2,718 words KG: ent-dise-e6019d4a
Contents

FUS Mutations in Amyotrophic Lateral Sclerosis

Disease Info
InheritanceAutosomal dominant
Transcription regulationActs as a transcriptional activator, interacting with RNA polymerase II and various transcription factors
Alternative splicingRegulates the splicing of numerous neuronal transcripts through interaction with splicing factors
RNA transportFacilitates transport of mRNAs to dendritic and axonal compartments
Translation regulationModulates translation at synapses
DNA damage responseParticipates in non-homologous end joining and other DNA repair pathways
Stress granule formationFUS is a key component of stress granules, cytoplasmic RNA-protein assemblies that form during cellular stress
PenetranceNear complete but age-dependent
De novo mutationsCommon, particularly for severe mutations like P525L
AnticipationNot typically observed
Founder effectsIdentified in some populations
N-terminal mutationsLess common, affect aggregation propensity
DatabasesOMIMOrphanetClinicalTrialsPubMed

No AI portrait yet

Knowledge Graph

Related Hypotheses (32)

Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.92
Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.78
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.77
Senescence-Induced Lipid Peroxidation Spreading
Score: 0.73
Circadian Rhythm Entrainment of Reactive Astrocytes
Score: 0.72
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.71
Lysosomal Enzyme Trafficking Correction
Score: 0.71
Lysosomal Calcium Channel Modulation Therapy
Score: 0.70
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.69
Ganglioside Rebalancing Therapy
Score: 0.69
Cross-Seeding Prevention Strategy
Score: 0.69
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69
Complement C1QA Spatial Gradient in Cortical Layers
Score: 0.68
Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.67
RNA Granule Nucleation Site Modulation
Score: 0.66
HCN1-Mediated Resonance Frequency Stabilization Therapy
Score: 0.65
Mitochondrial SPM Synthesis Platform Engineering
Score: 0.65
Serine/Arginine-Rich Protein Kinase Modulation
Score: 0.62
Low Complexity Domain Cross-Linking Inhibition
Score: 0.62
Netrin-1 Gradient Restoration
Score: 0.59
pg 1/2Next →

Related Analyses (25)

RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed
How do non-cell autonomous effects of autophagy dysfunction
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived

Related Experiments (11)

ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40
s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.40
TDP-43 PET Ligand Development for FTD and ALS
clinical · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
cGAS/STING pathway activation by TDP-43-released mtDNA
exploratory · proposed · Score: 0.95

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)